Managing myeloma kidney

Research output: Contribution to journalReview article

17 Citations (Scopus)

Abstract

Renal insufficiency is a challenging clinical problem in patients with multiple myeloma. The standard therapy has been plasma exchange, which reduces serum light chain levels while chemotherapy reduces the number of light chain-secreting malignant plasma cells. In this issue, Clark and colleagues' study challenges this widely held standard of patient management.

Original languageEnglish (US)
Pages (from-to)835-837
Number of pages3
JournalAnnals of Internal Medicine
Volume143
Issue number11
DOIs
StatePublished - Dec 6 2005

Fingerprint

Kidney
Light
Plasma Exchange
Plasma Cells
Multiple Myeloma
Renal Insufficiency
Drug Therapy
Serum
Therapeutics

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Managing myeloma kidney. / Gertz, Morie.

In: Annals of Internal Medicine, Vol. 143, No. 11, 06.12.2005, p. 835-837.

Research output: Contribution to journalReview article

Gertz, Morie. / Managing myeloma kidney. In: Annals of Internal Medicine. 2005 ; Vol. 143, No. 11. pp. 835-837.
@article{aae760469f974524900f856f9d5ec6f8,
title = "Managing myeloma kidney",
abstract = "Renal insufficiency is a challenging clinical problem in patients with multiple myeloma. The standard therapy has been plasma exchange, which reduces serum light chain levels while chemotherapy reduces the number of light chain-secreting malignant plasma cells. In this issue, Clark and colleagues' study challenges this widely held standard of patient management.",
author = "Morie Gertz",
year = "2005",
month = "12",
day = "6",
doi = "10.7326/0003-4819-143-11-200512060-00013",
language = "English (US)",
volume = "143",
pages = "835--837",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "11",

}

TY - JOUR

T1 - Managing myeloma kidney

AU - Gertz, Morie

PY - 2005/12/6

Y1 - 2005/12/6

N2 - Renal insufficiency is a challenging clinical problem in patients with multiple myeloma. The standard therapy has been plasma exchange, which reduces serum light chain levels while chemotherapy reduces the number of light chain-secreting malignant plasma cells. In this issue, Clark and colleagues' study challenges this widely held standard of patient management.

AB - Renal insufficiency is a challenging clinical problem in patients with multiple myeloma. The standard therapy has been plasma exchange, which reduces serum light chain levels while chemotherapy reduces the number of light chain-secreting malignant plasma cells. In this issue, Clark and colleagues' study challenges this widely held standard of patient management.

UR - http://www.scopus.com/inward/record.url?scp=28844507526&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=28844507526&partnerID=8YFLogxK

U2 - 10.7326/0003-4819-143-11-200512060-00013

DO - 10.7326/0003-4819-143-11-200512060-00013

M3 - Review article

C2 - 16330796

AN - SCOPUS:28844507526

VL - 143

SP - 835

EP - 837

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 11

ER -